Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Robert Driscoll maintains an Outperform rating on IDEAYA Biosciences (NASDAQ:IDYA) and raises the price target from $40 to $43.
September 12, 2023 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst maintains Outperform rating on IDEAYA Biosciences and raises the price target from $40 to $43, indicating positive outlook.
The raised price target by Wedbush analyst indicates a positive outlook for IDEAYA Biosciences. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100